Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about New two year data of Novartis Cosentyx showing no progression in joint damage in 84% of psoriatic arthritis patients
Novartis announced new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.
- Read more about Lupin receives FDA approval for generic loestrin®24 fe tablets
Pharma Major Lupin Limited (Lupin) announced that it has received final approval for its Blisovi 24 Fe Tablets (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate Tablets, 75 mg) from the United States Food and Drug Administration (FDA) to market a generic version of Warner Chilcott's Loestrin®24 Fe Tablets (Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate Tablets, 75 mg). Lupin’s US subsidiary, Lupin Pharmaceuticals Inc. would commence promoting the product shortly in the US.
- Read more about Drug addiction through painkiller more common in women
The route to drug addiction for most women could begin with doctor-prescribed painkillers, a new study warns.
- Read more about U.S. Food and Drug Administration Approves Gilead’s Genvoya® for Treatment of HIV-1 Infection
The U.S. Food and Drug Administration approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. Genvoya is marketed by Gilead Sciences Inc.
- Read more about FDA panel backs Merck & Co drug to reverse muscle relaxant effect
Merck & Co's drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug Administration said. The drug, which goes by the chemical name of sugammadex, has repeatedly been rejected by the FDA due to concerns about potentially dangerous allergic reactions, even though it is approved in more than 75 countries.
- Read more about AstraZeneca acquire ZS Pharma
AstraZeneca, a global, innovation-driven biopharmaceutical business acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California. ZS Pharma uses its proprietary ion¬-trap technology to develop novel treatments for hyperkalaemia (high potassium levels), a serious condition of elevated potassium in the bloodstream, typically associated with chronic kidney disease (CKD) and chronic heart failure (CHF).

[adsense:336x280:8701650588]
- Read more about World's first blood test for accurate prenatal testing
Scientists at Plymouth University have developed a non-invasive, low risk and accurate blood test that can detect foetal blood group, sex, and genetic conditions in unborn babies.
- Read more about Nestle announces Maggi's re-launch after five months
Nestle India said it has begun the roll-out of Maggi noodles and that the priority would now be to reach the popular snack to the consumers at the earliest.
- Read more about Cholesterol-lowering 'portfolio diet' cuts BP
A diet meant to cut cholesterol levels can also lower blood pressure, a new study has found.
- Read more about Cranberries can help curb urinary tract infections
Cranberries can help curb recurrent urinary tract infections (UTIs), the second most common type of infection in the body, says a study by an Indian-origin researcher.